Conca, Andreas

Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)

Martinotti, G., Vita, A., Fagiolini, A., Maina, G., Bertolino, A., Dell'Osso, B., Siracusano, A., Clerici, M., Bellomo, A., Sani, G., et al. (2022) · Journal of Affective Disorders

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 146

Consequences of the COVID-19 pandemic on admissions to general hospital psychiatric wards in Italy: reduced psychiatric hospitalizations and increased suicidality

Boldrini, T., Girardi, P., Clerici, M., Conca, A., Creati, C., Di Cicilia, G., Ducci, G., Durbano, F., Maci, C., Maone, A., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

COVID-19 and Mental HealthCOVID-19 and healthcare impacts

Cited by 90

Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response

Minelli, A., Abate, M., Zampieri, E., Gainelli, G., Trabucchi, L., Segala, M., Sartori, R., Gennarelli, M., Conca, A., & Bortolomasi, M. (2016) · The Journal of ECT

Electroconvulsive Therapy StudiesTreatment of Major Depression

Cited by 79

Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence

Cellini, L., De Donatis, D., Zernig, G., De Ronchi, D., Giupponi, G., Serretti, A., Xenia, H., Conca, A., & Florio, V. (2022) · International Clinical Psychopharmacology

Treatment of Major DepressionPharmacogenetics and Drug Metabolism

Cited by 24